These are the stocks posting the largest moves before the bell.Market Insiderread more
The next three weeks are among the rockiest, on a historical basis, of the entire calendar.Trading Nationread more
Removing Neumann is a difficult decision for Son, who has long believed in WeWork and Neumann's vision to quickly expand the company.Technologyread more
Of all the cases of economic espionage charged by the DOJ's National Security Division since 2012, more than 80% of them implicated China.World Politicsread more
Worries over global economic growth were set to thwart Wall Street's run to record highs on Monday.Marketsread more
Guggenheim reiterated its buy rating on Boston Beer Company's stock and raised its price target to $462 from $449 per share.Investingread more
In his new memoir, "The Ride of a Lifetime," Iger explains why he decided against the deal to buy Twitter.Technologyread more
Ad-tech company The Trade Desk is launching a campaign to show how it differs from tech giants like Google and Facebook.Technologyread more
The streaming wars may have claimed a new victim, and one technical analyst says it could be about to get worse.Trading Nationread more
"Whilst there is a big dispute at the moment, I think there's also potential for resolution," UBS chairman Axel Weber says of the U.S.-China trade negotiations.Singapore Summitread more
No quid pro quo, there was nothing," Trump said the call. "It was a perfect conversation."Politicsread more
"We are thrilled to welcome Jeff as the new independent chairman of the athenahealth Board," Dev Ittycheria, chair of the board's nominating and corporate governance committee said in a statement.
The health-care technology company, which provides network-enabled services for hospital and ambulatory clients, cited Immelt's "digital expertise" among the reasons for the appointment. In a statement, Athenahealth credited him with "driving the first wave of digitization across healthcare enterprises and the healthcare industry at large."
"Having considered a number of highly qualified candidates, the Board determined that Jeff's deep expertise and broad relationships in the healthcare industry, combined with his drive for industry transformation through innovation, ideally position him to be a great partner to the Board and management team as we work to profitably grow and scale the Company and drive value creation," Ittycheria added.
After 16 years as GE chairman and CEO, Immelt stepped down in October 2017.
Immelt led the company through the Sept. 11 attacks, the financial crisis and oil price swings. Under his leadership, GE sold or spun off major businesses, including appliances, insurance and plastics, as well as NBCUniversal, among others. Under Immelt, GE went from a far-flung conglomerate to an industrial company focused on the faster-growing industrial and power sectors.
But Immelt has come under fire by critics for poor leadership decisions that left GE cash strapped. He has been criticized for poorly timed investments and decisions about mergers and acquisitions. He's also been critiqued for excessive spending habits, including bringing an extra corporate jet on business trips — just in case of emergencies.
Immelt plans to purchase $1 million of Athenahealth common stock in the open market. Shares of Athenahealth gained 3.7 percent after the announcement.